vs
Side-by-side financial comparison of ENERGIZER HOLDINGS, INC. (ENR) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
ENERGIZER HOLDINGS, INC. is the larger business by last-quarter revenue ($778.9M vs $493.8M, roughly 1.6× Pediatrix Medical Group, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs -0.4%, a 7.3% gap on every dollar of revenue. On growth, ENERGIZER HOLDINGS, INC. posted the faster year-over-year revenue change (6.5% vs -1.7%). Over the past eight quarters, ENERGIZER HOLDINGS, INC.'s revenue compounded faster (8.4% CAGR vs -0.1%).
Energizer Holdings, Inc. is an American manufacturer and one of the world's largest manufacturers of batteries, headquartered in Clayton, Missouri. It produces batteries under the Energizer, Ray-O-Vac, Varta, and Eveready brand names and formerly owned several personal care businesses until it separated that side of the business into a new company called Edgewell Personal Care in 2015.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
ENR vs MD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $778.9M | $493.8M |
| Net Profit | $-3.4M | $33.7M |
| Gross Margin | 32.9% | — |
| Operating Margin | -0.6% | 9.9% |
| Net Margin | -0.4% | 6.8% |
| Revenue YoY | 6.5% | -1.7% |
| Net Profit YoY | -115.2% | 10.5% |
| EPS (diluted) | — | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $778.9M | $493.8M | ||
| Q3 25 | $832.8M | $492.9M | ||
| Q2 25 | $725.3M | $468.8M | ||
| Q1 25 | $662.9M | $458.4M | ||
| Q4 24 | $731.7M | $502.4M | ||
| Q3 24 | $805.7M | $511.2M | ||
| Q2 24 | $701.4M | $504.3M | ||
| Q1 24 | $663.3M | $495.1M |
| Q4 25 | $-3.4M | $33.7M | ||
| Q3 25 | $34.9M | $71.7M | ||
| Q2 25 | $153.5M | $39.3M | ||
| Q1 25 | $28.3M | $20.7M | ||
| Q4 24 | $22.3M | $30.5M | ||
| Q3 24 | $47.6M | $19.4M | ||
| Q2 24 | $-43.8M | $-153.0M | ||
| Q1 24 | $32.4M | $4.0M |
| Q4 25 | 32.9% | — | ||
| Q3 25 | 36.6% | — | ||
| Q2 25 | 55.1% | — | ||
| Q1 25 | 39.1% | — | ||
| Q4 24 | 36.8% | — | ||
| Q3 24 | 38.1% | — | ||
| Q2 24 | 39.5% | — | ||
| Q1 24 | 38.2% | — |
| Q4 25 | -0.6% | 9.9% | ||
| Q3 25 | 6.4% | 13.8% | ||
| Q2 25 | 22.6% | 12.8% | ||
| Q1 25 | 5.5% | 7.0% | ||
| Q4 24 | 4.1% | 7.8% | ||
| Q3 24 | 7.4% | 6.6% | ||
| Q2 24 | -8.2% | -31.3% | ||
| Q1 24 | 6.4% | 3.2% |
| Q4 25 | -0.4% | 6.8% | ||
| Q3 25 | 4.2% | 14.5% | ||
| Q2 25 | 21.2% | 8.4% | ||
| Q1 25 | 4.3% | 4.5% | ||
| Q4 24 | 3.0% | 6.1% | ||
| Q3 24 | 5.9% | 3.8% | ||
| Q2 24 | -6.2% | -30.3% | ||
| Q1 24 | 4.9% | 0.8% |
| Q4 25 | — | $0.40 | ||
| Q3 25 | — | $0.84 | ||
| Q2 25 | — | $0.46 | ||
| Q1 25 | — | $0.24 | ||
| Q4 24 | — | $0.37 | ||
| Q3 24 | — | $0.23 | ||
| Q2 24 | — | $-1.84 | ||
| Q1 24 | — | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $214.8M | $375.2M |
| Total DebtLower is stronger | — | $570.5M |
| Stockholders' EquityBook value | $141.3M | $865.9M |
| Total Assets | $4.4B | $2.2B |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $214.8M | $375.2M | ||
| Q3 25 | $236.2M | $340.1M | ||
| Q2 25 | $171.1M | $224.7M | ||
| Q1 25 | $139.3M | $99.0M | ||
| Q4 24 | $195.9M | $229.9M | ||
| Q3 24 | $216.9M | $103.8M | ||
| Q2 24 | $146.7M | $19.4M | ||
| Q1 24 | $158.1M | $8.0M |
| Q4 25 | — | $570.5M | ||
| Q3 25 | $3.4B | $577.2M | ||
| Q2 25 | $3.2B | $583.9M | ||
| Q1 25 | $3.2B | $590.5M | ||
| Q4 24 | $3.1B | $597.1M | ||
| Q3 24 | $3.2B | — | ||
| Q2 24 | $3.2B | — | ||
| Q1 24 | $3.2B | — |
| Q4 25 | $141.3M | $865.9M | ||
| Q3 25 | $169.9M | $890.7M | ||
| Q2 25 | $183.2M | $833.8M | ||
| Q1 25 | $133.9M | $789.2M | ||
| Q4 24 | $140.6M | $764.9M | ||
| Q3 24 | $135.8M | $732.5M | ||
| Q2 24 | $123.4M | $706.5M | ||
| Q1 24 | $191.3M | $856.2M |
| Q4 25 | $4.4B | $2.2B | ||
| Q3 25 | $4.6B | $2.2B | ||
| Q2 25 | $4.5B | $2.1B | ||
| Q1 25 | $4.2B | $2.0B | ||
| Q4 24 | $4.2B | $2.2B | ||
| Q3 24 | $4.3B | $2.1B | ||
| Q2 24 | $4.2B | $2.0B | ||
| Q1 24 | $4.3B | $2.2B |
| Q4 25 | — | 0.66× | ||
| Q3 25 | 20.28× | 0.65× | ||
| Q2 25 | 17.57× | 0.70× | ||
| Q1 25 | 23.56× | 0.75× | ||
| Q4 24 | 22.17× | 0.78× | ||
| Q3 24 | 23.51× | — | ||
| Q2 24 | 26.04× | — | ||
| Q1 24 | 16.86× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $149.5M | $114.1M |
| Free Cash FlowOCF − Capex | $124.2M | — |
| FCF MarginFCF / Revenue | 15.9% | — |
| Capex IntensityCapex / Revenue | 3.2% | — |
| Cash ConversionOCF / Net Profit | — | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $145.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $149.5M | $114.1M | ||
| Q3 25 | $61.5M | $137.3M | ||
| Q2 25 | $21.4M | $137.2M | ||
| Q1 25 | $-12.8M | $-117.5M | ||
| Q4 24 | $77.0M | $133.0M | ||
| Q3 24 | $168.9M | $91.8M | ||
| Q2 24 | $45.8M | $107.0M | ||
| Q1 24 | $36.8M | $-125.2M |
| Q4 25 | $124.2M | — | ||
| Q3 25 | $46.7M | — | ||
| Q2 25 | $7.9M | — | ||
| Q1 25 | $-33.8M | — | ||
| Q4 24 | $42.4M | — | ||
| Q3 24 | $141.5M | — | ||
| Q2 24 | $27.3M | — | ||
| Q1 24 | $10.3M | — |
| Q4 25 | 15.9% | — | ||
| Q3 25 | 5.6% | — | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | -5.1% | — | ||
| Q4 24 | 5.8% | — | ||
| Q3 24 | 17.6% | — | ||
| Q2 24 | 3.9% | — | ||
| Q1 24 | 1.6% | — |
| Q4 25 | 3.2% | — | ||
| Q3 25 | 1.8% | — | ||
| Q2 25 | 1.9% | — | ||
| Q1 25 | 3.2% | — | ||
| Q4 24 | 4.7% | — | ||
| Q3 24 | 3.4% | — | ||
| Q2 24 | 2.6% | — | ||
| Q1 24 | 4.0% | — |
| Q4 25 | — | 3.39× | ||
| Q3 25 | 1.76× | 1.91× | ||
| Q2 25 | 0.14× | 3.49× | ||
| Q1 25 | -0.45× | -5.66× | ||
| Q4 24 | 3.45× | 4.36× | ||
| Q3 24 | 3.55× | 4.72× | ||
| Q2 24 | — | — | ||
| Q1 24 | 1.14× | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ENR
| Alkaline Batteries | $666.5M | 86% |
| Auto Care | $93.7M | 12% |
| Lights | $18.7M | 2% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
